11/18
08:45 am
dwtx
Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study
High
Report
Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study
11/7
07:05 am
dwtx
Dogwood Therapeutics Announces Third Quarter 2024 Financial Results
Medium
Report
Dogwood Therapeutics Announces Third Quarter 2024 Financial Results
10/31
09:15 am
dwtx
Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024
Medium
Report
Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024
10/30
09:15 am
dwtx
Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
Medium
Report
Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement